SCNT-hES-RPE cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SCNT-hES-RPE cells, covering 2017-10-09 to 2017-10-09. Get the full timeline:
Most recent: Clinical Trial Update: The Safety and Tolerability of Sub-retinal Transplantation of SCNT-hES-RPE Cells in Patients With Advanced Dry AMD [Phase 1]